EAHP Statement 3: Production and Compounding

Showing results 11 - 20 of 100

Sorted by most recent

TitleAuthorDate

Container closure integrity testing and process validation of closed system transfer devices for aseptic reconstitution of drug vials connected to fluid bags

Roland B van den Berg, Kübra Akgöl, Eleonora L Swart, Bastiaan Nuijen, Mirjam Crul

15 February 2023

Formulation and stability study of an oral paediatric phenobarbital 1% solution containing hydroxypropyl-β-cyclodextrins

Louise Parrenne, Zoé Ribier, Jonathan Abisror, Jules Cadix, Guy Benoit, Joelle Bordenave

8 February 2023

Analysis of production time and capacity for manual and robotic compounding scenarios for parenteral hazardous drugs

Tjerk H Geersing, Demelza M Pourahmad, Femke Lodewijk, Eric J F Franssen, Catherijne A J Knibbe, Mirjam Crul

15 February 2023

Optimised quality control method for determination of the radiochemical purity of [Tc]Tc-mebrofenin and [Tc]Tc-etifenin in a clinical context

Charlotte Pirot, Damien Peyronnet, Jonathan Vigne

23 January 2023

Physical compatibility of ceftriaxone and cefepime in 0.45% sodium chloride, Ringer’s lactate solution, and Plasma-Lyte A

Megan Kelley, Chloe Spooneybarger, Mitchell Howard, Justin Reinert, Mariann D Churchwell, Gabriella Baki

11 June 2024

Losartan potassium liquid formulation for paediatric hospital use: development and stability evaluation

Augusto César Corte, Caren Gobetti, Graciela Carlos, Sílvia Helena de Oliveira Almeida, Márcio Vinícius Ayres, Martin Steppe, Cassia Virginia Garcia

9 May 2024

Impact of implementing the aseptic compounding management system, Medcura, on internal error rates within an oncology pharmacy aseptic unit: a mixed methods evaluation

Emily Smith, Andy Fox, Graeme Willmers, Deborah Wright, Beth Stuart

14 October 2022

Safe handling of cytostatic drugs: recommendations from independent science

Mirjam Crul, oscar Breukels

16 September 2022

Physicochemical stability of pevonedistat at 50, 100 and 200 µg/mL diluted in 0.9% sodium chloride and at 10 mg/mL in partially used vials

Ralitsa Doncheva, Elise D'Huart, Nathalie Sobalak, Jean Vigneron, Béatrice Demoré

26 February 2024

Quality assurance standards and their use in the preparation of parenteral systemic anticancer therapy products in healthcare establishments: a scoping review

Kevin D Murphy, Cian O' Mahony, Megan McCarthy, Mohamad M Saab, Teresa M Barbosa, Aoife Fleming, Patrick Cotter, Brendan Noonan, Elizabeth Breen, Grant Carroll, AnneMarie De Frein, Patricia Heckmann, Margaret Triggs, Laura Sahm

25 October 2023

Prev 123 4 5 6 7 8 9 10 Next